Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$711,822
+$40,944 QoQ
Shares Held
4,542
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#743
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. NVS ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
This page
|
4,542 | $711,822 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $711,822 | 4,542 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $670,878 | 4,392 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $564,164 | 4,092 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $450,378 | 3,512 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $478,231 | 3,952 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $440,568 | 3,952 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $384,569 | 3,952 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $421,203 | 3,662 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $379,210 | 3,562 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $334,879 | 3,462 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $349,558 | 3,462 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $351,620 | 3,452 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $266,604 | 2,642 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $245,180 | 2,665 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $348,818 | 3,845 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $292,258 | 3,845 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $325,017 | 3,845 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $337,398 | 3,845 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $336,322 | 3,845 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $314,444 | 3,845 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $350,817 | 3,845 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $328,670 | 3,845 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $584,993 | 6,195 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $538,717 | 6,195 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $541,071 | 6,195 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $357,997 | 4,342 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||